Clinical Trial Update: Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating gadobutrol 1.0 M (Gadovist) for breast MRI in breast cancer patients has completed. The posted results assess efficacy as an MRI cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gadovist (gadobutrol)

Snippet

Sponsor: Bayer | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-11-11